Maha Ayyoub Selected Research

peptide NY-ESO-1 157-165

5/2005

Distinct structural TCR repertoires in naturally occurring versus vaccine-induced CD8+ T-cell responses to the tumor-specific antigen NY-ESO-1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maha Ayyoub Research Topics

Disease

57	Neoplasms (Cancer) 01/2021 - 02/2002
21	Melanoma (Melanoma, Malignant) 01/2021 - 02/2002
8	Testicular Neoplasms (Testicular Cancer) 10/2014 - 06/2004
6	Ovarian Neoplasms (Ovarian Cancer) 07/2020 - 08/2007
4	Colorectal Neoplasms (Colorectal Cancer) 12/2020 - 09/2006
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 04/2016
3	Ovarian Epithelial Carcinoma 01/2011 - 01/2006
3	Sarcoma (Soft Tissue Sarcoma) 08/2007 - 10/2003
3	Synovial Sarcoma (Synovioma) 08/2007 - 06/2004
2	Colonic Neoplasms (Colon Cancer) 12/2020 - 06/2008
2	Lung Neoplasms (Lung Cancer) 01/2020 - 03/2012
2	Breast Neoplasms (Breast Cancer) 02/2014 - 01/2011
1	Lymphoma (Lymphomas) 01/2021
1	Kidney Neoplasms (Kidney Cancer) 07/2020
1	Ascites 01/2020
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2020
1	Colitis 11/2019
1	Philadelphia Chromosome 01/2016
1	Ductal Carcinoma 01/2011
1	Inflammation (Inflammations) 05/2009
1	Autoimmune Diseases (Autoimmune Disease) 02/2009
1	Hepatocellular Carcinoma (Hepatoma) 08/2007
1	Vaccinia 09/2006
1	Fowlpox 09/2006
1	Disease Progression 11/2005
1	Neoplasm Metastasis (Metastasis) 05/2004
1	Human Influenza (Influenza) 03/2004

Drug/Important Bio-Agent (IBA)

33	AntigensIBA 01/2021 - 08/2002
16	Peptides (Polypeptides)IBA 01/2020 - 02/2002
15	Neoplasm Antigens (Tumor Antigens)IBA 01/2021 - 10/2002
12	VaccinesIBA 09/2010 - 10/2002
10	Proteins (Proteins, Gene)FDA Link 02/2009 - 04/2004
7	Cancer VaccinesIBA 01/2009 - 10/2003
7	EpitopesIBA 08/2007 - 02/2002
5	MART-1 AntigenIBA 10/2006 - 10/2002
4	Immunodominant EpitopesIBA 09/2010 - 04/2004
3	CytokinesIBA 01/2021 - 02/2009
3	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2016
3	AntibodiesIBA 11/2019 - 10/2002
3	LigandsIBA 01/2014 - 08/2002
3	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 04/2004 - 02/2002
2	Tumor Necrosis Factor InhibitorsIBA 01/2021 - 11/2019
2	Infliximab (Remicade)FDA Link 01/2021 - 11/2019
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2014
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2019 - 02/2009
2	Pharmaceutical PreparationsIBA 01/2016 - 12/2014
2	Hormones (Hormone)IBA 02/2014 - 01/2011
2	InterleukinsIBA 01/2014 - 02/2009
2	Interleukin-2 (IL2)IBA 05/2009 - 02/2009
2	Monatide (IMS 3015)IBA 01/2009 - 05/2007
2	HLA-DR Antigens (HLA-DR)IBA 08/2007 - 04/2004
2	CPG-oligonucleotideIBA 05/2007 - 03/2004
2	HLA-A2 Antigen (HLA A2 Antigen)IBA 05/2004 - 09/2003
1	RNA (Ribonucleic Acid)IBA 01/2021
1	IpilimumabIBA 01/2021
1	NivolumabIBA 01/2021
1	Thymidine Monophosphate (TMP)IBA 01/2020
1	OX40 ReceptorsIBA 01/2019
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	Monoclonal AntibodiesIBA 12/2014
1	Progesterone Receptors (Progesterone Receptor)IBA 02/2014
1	Estrogen ReceptorsIBA 02/2014
1	human ERBB2 proteinIBA 02/2014
1	Tyrosine Kinase InhibitorsIBA 01/2014
1	micaIBA 01/2014
1	Cytotoxins (Cytolysins)IBA 01/2014
1	Blocking AntibodiesIBA 01/2014
1	MHC class I-related chain AIBA 01/2014
1	Sorafenib (BAY 43-9006)FDA Link 01/2014
1	Temozolomide (Temodar)FDA LinkGeneric 01/2014
1	VemurafenibIBA 01/2014
1	Complement System Proteins (Complement)IBA 01/2011
1	AutoantigensIBA 04/2010
1	Tryptophan (L-Tryptophan)FDA Link 07/2009
1	Interleukin-17 (Interleukin 17)IBA 05/2009
1	Interferon-gamma (Interferon, gamma)IBA 02/2009
1	Recombinant ProteinsIBA 02/2009
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 02/2009
1	Transforming Growth Factor beta (TGF-beta)IBA 02/2009
1	PerforinIBA 09/2006
1	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 10/2005
1	peptide NY-ESO-1 157-165IBA 05/2005
1	Protein Subunit VaccinesIBA 05/2005
1	HLA-DPB1 antigen (HLA DPB1)IBA 06/2004
1	saponin QA-21V1 (QS21)IBA 05/2004
1	Immunologic Adjuvants (Immunologic Adjuvant)IBA 05/2004
1	incomplete Freund's adjuvantIBA 10/2003
1	HLA-A*02:01 antigenIBA 02/2003
1	Peptide LibraryIBA 08/2002
1	Proteasome Endopeptidase Complex (Proteasome)IBA 02/2002

Therapy/Procedure

25	Immunotherapy 01/2021 - 02/2002
14	Therapeutics 01/2021 - 10/2003
2	Drug Therapy (Chemotherapy) 01/2020 - 01/2014
1	Radiotherapy 01/2021
1	Precision Medicine 01/2016
1	Cell- and Tissue-Based Therapy (Cell Therapy) 02/2013